Trials / Completed
CompletedNCT01083888
ASP1517 Pharmacokinetics Study in Anemia Patients on Hemodialysis
ASP1517 Clinical Pharmacological Study Examination of Pharmacokinetics and Pharmacodynamics in Patients With Renal Anemia Undergoing Hemodialysis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To assess the Pharmacokinetics and pharmacodynamics of single doses of ASP1517 in renal anemia patients on hemodialysis. Safety and tolerability will be also evaluated in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | roxadustat | oral |
Timeline
- Start date
- 2010-02-15
- Primary completion
- 2010-06-07
- Completion
- 2010-06-07
- First posted
- 2010-03-10
- Last updated
- 2024-10-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01083888. Inclusion in this directory is not an endorsement.